» Articles » PMID: 20145141

General Transcription Factor Binding at CpG Islands in Normal Cells Correlates with Resistance to De Novo DNA Methylation in Cancer Cells

Overview
Journal Cancer Res
Specialty Oncology
Date 2010 Feb 11
PMID 20145141
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Aberrant DNA methylation at CpG islands is thought to contribute to cancer initiation and progression, but mechanisms that establish and maintain DNA methylation status during tumorigenesis or normal development remain poorly understood. In this study, we used methyl-CpG immunoprecipitation to generate comparative DNA methylation profiles of healthy and malignant cells (acute leukemia and colorectal carcinoma) for human CpG islands across the genome. While searching for sequence patterns that characterize DNA methylation states, we discovered several nonredundant sequences in CpG islands that were resistant to aberrant de novo methylation in cancer and that resembled consensus binding sites for general transcription factors (TF). Comparing methylation profiles with global CpG island binding data for specific protein 1, nuclear respiratory factor 1, and yin-yang 1 revealed that their DNA binding activity in normal blood cells correlated strictly with an absence of de novo methylation in cancer. In addition, global evidence showed that binding of any of these TFs to their consensus motif depended on their co-occurrence with neighboring consensus motifs. In summary, our results had two major implications. First, they pointed to a major role for cooperative binding of TFs in maintaining the unmethylated status of CpG islands in health and disease. Second, our results suggest that the majority of de novo methylated CpG islands are characterized by the lack of sequence motif combinations and the absence of activating TF binding.

Citing Articles

MethNet: a robust approach to identify regulatory hubs and their distal targets from cancer data.

Sakellaropoulos T, Do C, Jiang G, Cova G, Meyn P, Dimartino D Nat Commun. 2024; 15(1):6027.

PMID: 39025865 PMC: 11258126. DOI: 10.1038/s41467-024-50380-3.


Oncoprotein LAMTOR5-mediated CHOP silence via DNA hypermethylation and miR-182/miR-769 in promotion of liver cancer growth.

Wang X, Li Q, Tang Y, Li Y, Zhang L, Xu F Acta Pharmacol Sin. 2024; 45(12):2625-2645.

PMID: 38942954 PMC: 11579023. DOI: 10.1038/s41401-024-01310-y.


Identification of Eleutherococcus senticosus NAC transcription factors and their mechanisms in mediating DNA methylation of EsFPS, EsSS, and EsSE promoters to regulate saponin synthesis.

Dong J, Zhao X, Song X, Wang S, Zhao X, Liang B BMC Genomics. 2024; 25(1):536.

PMID: 38816704 PMC: 11140872. DOI: 10.1186/s12864-024-10442-8.


DNA methylation regulates the secondary metabolism of saponins to improve the adaptability of Eleutherococcus senticosus during drought stress.

Wang S, Zhao X, Li C, Dong J, Ma J, Long Y BMC Genomics. 2024; 25(1):330.

PMID: 38565995 PMC: 10986080. DOI: 10.1186/s12864-024-10237-x.


Role of epigenetics and the transcription factor Sp1 in the expression of the D prostanoid receptor 1 in human cartilage.

Najar M, Alsabri S, Guedi G, Merimi M, Lavoie F, Grabs D Front Cell Dev Biol. 2023; 11:1256998.

PMID: 38099292 PMC: 10720455. DOI: 10.3389/fcell.2023.1256998.